Indication:Soliris is indicated for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis.

Dosage Form:Injection

Active Ingredients:Eculizumab

Route of Administration:Intravenous Drip

Shelf Life:18 months

Storage:2℃-8℃

Package:1 vial per carton

Place of Origin:EU

Qualification:EU GMP

Indication:For the treatment of advanced or metastatic renal cell cancer (RCC). For the first-line treatment of metastatic renal cell cancer (RCC).

Dosage Form:Capsule

Active Ingredients:cabozantinib

Route of Administration:Oral

Shelf Life:18 months

Storage:Below 25℃

Package:20/80mg 56 hard capsules

Place of Origin:EU

Qualification:EU GMP

CAS:956-84-3

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:13979-80-1

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:948-43-6

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:1194374-08-7

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:16215-47-7

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:160808-60-6

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:160808-60-6

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:14475-60-6

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:2213-51-6

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:569339-15-7

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:51149-87-2

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:643093-96-3

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:211734-87-1

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:38965-71-8

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:107146-56-5

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:112641-26-6

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:3160-38-1

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed

CAS:25022-55-3

Pharmacopeia:CP

Shelf Life:18 months

Storage:Sealed